BPH management: New paradigms, new approaches
November 1st 2003The paradigm for the medical management of benign prostatic hyperplasia has undergone a significant change during the past decade. Guided by new research, the approval of novel pharmaceutical and minimally invasive therapies, and the economics of health care financing, physicians have altered their approach to patient care in distinct ways.
Resistance to common UTI drugs continues to grow
November 1st 2003Chicago-Resistance to drugs commonly used against uncomplicated urinary tract infections continues to grow, according to the results of a large North American study presented at the 43rd Interscience Conference on Antimicrobials and Chemotherapy.
New formulas may be better for determining radiation therapy failure
October 30th 2003Salt Lake City--Prostate cancer researchers say they have developed methods to predict treatment failure in men undergoing radiation therapy that is more precise and specific than current American Society for Therapeutic Radiology and Oncology guidelines.
High-dose radiation for PCa effective at 10 years, has few side effects
October 30th 2003Salt Lake City--New research shows that men with clinically localized prostate cancer who are treated to high dose levels with three-dimensional conformal radiation therapy achieve long-term PSA relapse-free survival with minimal side effects.
Dr. See appointed chair of new Medical College of Wisconsin department
October 9th 2003The Board of Trustees of the Medical College of Wisconsin, Milwaukee,has approved the conversion of its division of urology to departmental status.William A. See, MD, has been appointed chairman of the new department.
Telephone management called safe for treating cystitis
October 9th 2003Large-scale telephone-based management of eligible women with presumedcystitis is associated with low clinical recurrence rates and a very lowincidence of other gynecourologic diagnoses, according to a study by a largeHMO in California.
New technology can detect low-level PSA following prostatectomy
October 9th 2003Scientists at Northwestern University have developed an ultra-sensitivetechnology based on gold nanoparticles and DNA that can detect PSA whenpresent at extremely low levels in the blood sample. The new protein-detectionmethod could be used to monitor prostate cancer patients following surgery,according to the researchers, whose findings are published in the Sept.26 issue of the journal Science (2003; 301:1884-6).
Prostate Ca screening interval of 4 years misses few cancers
October 9th 2003A 4-year screening interval was found adequate for detecting most cancersin a large European randomized trial of prostate cancer screening, accordingto a study in the Oct. 1 issue of the Journal of the National CancerInstitute (2003; 95:1462-6).
Operative delay predicts cancer return after cystectomy
October 1st 2003Montreal, Quebec-The interval between transurethral resection of bladdertumor and radical cystectomy significantly influences 3-year disease recurrencerates in patients with transitional cell carcinoma of the bladder, saidresearchers from McGill University in Montreal.
Platinum-based chemo shows modest benefit in bladder Ca
October 1st 2003Chicago-Neoadjuvant platinum-based chemotherapy is associatedwith a statistically significant improvement in the overall survival ofpatients with locally advanced bladder cancer, according to the resultsof a recent meta-analysis presented at the AUA annual meeting here. However,the treatment benefit is not strong enough to support a recommendation forusing neoadjuvant chemotherapy in this setting, said Amir Sherif, MD, PhD,speaking on behalf of the Nordic Cooperative Bladder Cancer Group.
Model predicts benefit of RP over watchful waiting
October 1st 2003Albuquerque, NM-A new outcome model of prostate cancer progression followingradical prostatectomy has demonstrated good correlation between the model'spredictions and actual patient data. A study using this model suggests thatmen benefit more from radical prostatectomy over watchful waiting, evenif residual disease remains after surgery.
Lithotriptors show no significant outcome differences
October 1st 2003Edinburgh, Scotland-When used by the same operators in a single center, shockwave lithotriptors of different power generators provide comparable results and have similar complication rates in the treatment of renal stones, urologists at a Scottish stone center reported at the AUA annual meeting.
Enzyme inhibitors may help in cancer therapy following initial procedures
September 25th 2003Certain enzyme inhibitors may slow tumor formation within weeks and could lead to treatments that retard or prevent recurrences of cancers, researchers at UT Southwestern Medical Center at Dallas have discovered.
Disease-causing genetic mutations in sperm increase with age
September 25th 2003Older men's sperm is more likely to contain disease-causing genetic mutations, suggests an analysis of sperm from men of various ages by scientists from the McKusick-Nathans Institute for Genetic Medicine at Johns Hopkins University, Baltimore.
AMA applauds Texas medical liability victory
September 25th 2003Texas patients and physicians scored a major victory when voters approved Proposition 12, a constitutional amendment that authorizes the legislature to determine limitations on non-economic damages in medical liability cases. The vote ratifies the state's recently enacted medical liability reforms.
Surgical mishaps more common in physician offices than ASCs
September 25th 2003Patients undergoing surgery in ambulatory surgery centers are safer than those who undergo procedures in doctors' offices, although the relative risk of death or injury is low in both types of facilities, a new Florida study indicates.